Showing 3811-3820 of 5773 results for "".
- Samsara Vision to Initiate a US PMA Supplemental Study of the SING IMT, a New-Generation Technology for AMDhttps://modernod.com/news/samsara-vision-to-initiate-a-us-pma-supplemental-study-of-the-sing-imt-a-new-generation-technology-for-amd/2480785/Samsara Vision announced FDA approval to initiate a US-based, PMA supplemental study to evaluate improvements in visual acuity and the safety of its SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) in people living with late-stage AMD. The CONCERTO trial w
- Allergan to Present New Data from its Eye Care Portfolio at ASCRS 2022https://modernod.com/news/allergan-to-present-new-data-from-its-eye-care-portfolio-at-ascrs-2022/2480778/Allergan announced that it will present new data from its eye care portfolio at the 2022 ASCRS annual meeting being held April 22–26 in Washington, DC. Presentations will include new data on Vuity (pilocarpine HCl ophthalmic solution) 1.25%, the first and only
- Oyster Point Pharma to Present New Clinical Data at ASCRS 2022https://modernod.com/news/oyster-point-pharma-to-present-new-clinical-data-at-ascrs-2022/2480775/Oyster Point Pharma announced the presentation of data analyses at the American Society of Cataract and Refractive Surgery (ASCRS), being held on April 22-26. The company-sponsored clinical trials that will be presented highlight the recently approved Tyrvaya (varenicline solution)
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack Advancehttps://modernod.com/news/nova-eye-medical-launches-next-generation-canaloplasty-device-for-glaucoma-itrack-advance/2480774/Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific. The iTrack Advance features the proprietary illuminated fiber optic tip of the original iTrack device, which all
- Lumibird Medical Launches Nd:YAG Laser Capsulohttps://modernod.com/news/lumibird-medical-launches-new-ndyag-laser-capsulo/2480767/Lumibird Group, the parent company of Quantel Medical, announced the launch of the Capsulo Nd:YAG laser. Lumibird says the device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. &ld
- Orasis Pharmaceuticals to Present New Data on Novel Presbyopia Candidate at ASCRShttps://modernod.com/news/orasis-pharmaceuticals-to-present-new-data-on-novel-presbyopia-candidate-at-ascrs/2480764/Orasis Pharmaceuticals announced that it will present new data on its novel eye drop candidate, CSF-1, at the 2022 American Society for Cataract and Refractive Surgery (ASCRS) annual meeting being held April 22-26 in Washington, D.C. "We look forward to these present
- Alcon Introduces Virtual Reality Surgical Training Technologyhttps://modernod.com/news/alcon-introduces-virtual-reality-surgical-training-technology/2480761/Alcon announced the launch of the Alcon Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator, a portable VR tool for cataract surgeons-in-training. As part of the Alcon Experience Academy, the VR simulator of
- Aurion Biotech Raises $120 Million to Advance its Cell Therapy Programhttps://modernod.com/news/aurion-biotech-raises-120-million-to-advance-its-cell-therapy-program/2480760/Aurion Biotech announced it has secured a $120 million financing with biotech and ophthalmology investors. The company intends to use the proceeds of the financing to advance its cell therapy program for corneal edema secondary to endothelial dysfunction, which affects approximately 16
- Nicox’s NCX 470 Dolomites Phase 2 Results Published in Journal of Glaucomahttps://modernod.com/news/nicoxs-ncx-470-dolomites-phase-2-results-published-in-journal-of-glaucoma/2480758/Nicox announced that the results from its Dolomites phase 2 clinical trial of NCX 470 in patients with open-angle glaucoma or ocular hypertension have been published online by the Journal of Glaucoma. The publication “A R
- Opus Enters Strategic Collaboration with Resilience for AAV-based Gene Therapy Development and Manufacturing for Inherited Retinal Diseaseshttps://modernod.com/news/opus-enters-strategic-collaboration-with-resilience-for-aav-based-gene-therapy-development-and-manufacturing-for-inherited-retinal-diseases/2480756/Opus Genetics announced a strategic manufacturing services agreement with National Resilience, a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, to support the development and manufacturing of Opus’ pipeline. Resilience